W. P. Geus

789 total citations
22 papers, 598 citations indexed

About

W. P. Geus is a scholar working on Surgery, Gastroenterology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, W. P. Geus has authored 22 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 11 papers in Gastroenterology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in W. P. Geus's work include Helicobacter pylori-related gastroenterology studies (10 papers), Gastroesophageal reflux and treatments (9 papers) and Gastrointestinal motility and disorders (4 papers). W. P. Geus is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (10 papers), Gastroesophageal reflux and treatments (9 papers) and Gastrointestinal motility and disorders (4 papers). W. P. Geus collaborates with scholars based in Netherlands, United Kingdom and United States. W. P. Geus's co-authors include Ron A. A. Mathôt, Alexander A. Vinks, Ben A. van Hout, Ernst J. Kuipers, Nicole Hunfeld, C. B. H. W. Lamers, K. H. Gan, Harry Heijerman, Paul Mulder and W. Bakker and has published in prestigious journals such as Gastroenterology, Thorax and Clinical Pharmacology & Therapeutics.

In The Last Decade

W. P. Geus

20 papers receiving 577 citations

Peers

W. P. Geus
Randolph E. Regal United States
Sheila M. Wilhelm United States
Linda Awdishu United States
William A. Edwards United States
J. Hosie United Kingdom
Andrew D. Blair United States
Randolph E. Regal United States
W. P. Geus
Citations per year, relative to W. P. Geus W. P. Geus (= 1×) peers Randolph E. Regal

Countries citing papers authored by W. P. Geus

Since Specialization
Citations

This map shows the geographic impact of W. P. Geus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. P. Geus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. P. Geus more than expected).

Fields of papers citing papers by W. P. Geus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. P. Geus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. P. Geus. The network helps show where W. P. Geus may publish in the future.

Co-authorship network of co-authors of W. P. Geus

This figure shows the co-authorship network connecting the top 25 collaborators of W. P. Geus. A scholar is included among the top collaborators of W. P. Geus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. P. Geus. W. P. Geus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hunfeld, Nicole, Daan J. Touw, Ron A. A. Mathôt, et al.. (2009). A comparison of the acid‐inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism. Alimentary Pharmacology & Therapeutics. 31(1). 150–159. 38 indexed citations
3.
Hunfeld, Nicole, Ron A. A. Mathôt, Daan J. Touw, et al.. (2008). Effect of CYP2C19 *2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians. British Journal of Clinical Pharmacology. 65(5). 752–760. 68 indexed citations
4.
Hunfeld, Nicole, W. P. Geus, & Ernst J. Kuipers. (2006). Systematic review: rebound acid hypersecretion after therapy with proton pump inhibitors. Alimentary Pharmacology & Therapeutics. 25(1). 39–46. 50 indexed citations
5.
Geus, W. P., Ron A. A. Mathôt, Paul Mulder, & C. B. H. W. Lamers. (2000). Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori‐negative subjects. Alimentary Pharmacology & Therapeutics. 14(8). 1057–1064. 21 indexed citations
6.
Geus, W. P.. (2000). Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?. PubMed. 10–20. 14 indexed citations
7.
Geus, W. P., et al.. (1999). Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: Characterization of tolerance. Clinical Pharmacology & Therapeutics. 66(2). 140–151. 27 indexed citations
8.
9.
Mathôt, Ron A. A., et al.. (1999). Impact of Goal-Oriented and Model-Based Clinical Pharmacokinetic Dosing of Aminoglycosides on Clinical Outcome: A Cost-Effectiveness Analysis. Therapeutic Drug Monitoring. 21(1). 63–73. 170 indexed citations
10.
Geus, W. P.. (1999). 153. Simultaneously measured duodenal and gastric pH in patients with cystic fibrosis: effect of omeprazole. The Netherlands Journal of Medicine. 54. S63–S63. 1 indexed citations
11.
Gan, K. H., W. P. Geus, C. B. H. W. Lamers, & Harry Heijerman. (1997). Effect of Omeprazole 40 mg Once Daily on Intraduodenal and Intragastric pH in H. Pylori-Negative Healthy Subjects. Digestive Diseases and Sciences. 42(11). 2304–2309. 27 indexed citations
12.
Smout, A. J. P. M., et al.. (1996). Gastro-oesophageal Reflux Disease in the Netherlands. Results of a Multicentre pH Study. Scandinavian Journal of Gastroenterology. 31(sup218). 10–15. 49 indexed citations
13.
Gan, K. H., W. P. Geus, W.W. Bakker, C. B. H. W. Lamers, & Harry Heijerman. (1996). In vitro dissolution profiles of enteric‐coated microsphere/microtablet pancreatin preparations at different pH values. Alimentary Pharmacology & Therapeutics. 10(5). 771–775. 18 indexed citations
14.
Gan, K. H., et al.. (1995). In vitro dissolution profiles of enteric-coated microsphere pancreatin preparations at different pH values. The Netherlands Journal of Medicine. 47(2). A35–A36. 1 indexed citations
15.
Gan, K. H., W. P. Geus, W. Bakker, C B Lamers, & Harry Heijerman. (1995). Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years.. Thorax. 50(12). 1301–1304. 61 indexed citations
16.
Gan, K. H., Harry Heijerman, W. P. Geus, W. Bakker, & C. B. H. W. Lamers. (1994). Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients. Alimentary Pharmacology & Therapeutics. 8(6). 603–607. 15 indexed citations
17.
Geus, W. P., et al.. (1994). Pattern of 72-hour intragastric acidity in a homogeneous group of intensive care unit patients. Digestive Diseases and Sciences. 39(8). 1608–1612. 3 indexed citations
18.
Geus, W. P., et al.. (1993). Comparison of two intravenous ranitidine regimens in a homogeneous population of intensive care unit patients. Alimentary Pharmacology & Therapeutics. 7(4). 451–457. 7 indexed citations
19.
Geus, W. P., Alexander A. Vinks, & C. B. H. W. Lamers. (1992). Pharmacokinetics of Ranitidine in a Homogeneous Population of Intensive Care Unit Patients during Intermittent and Continuous Administration. Scandinavian Journal of Gastroenterology. 27(sup194). 55–58. 2 indexed citations
20.
Geus, W. P. & C. B. H. W. Lamers. (1990). Prevention of Stress Ulcer Bleeding: A Review. Scandinavian Journal of Gastroenterology. 25(sup178). 32–41. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026